Home > News

News

Researchers develop first functional targeted inhibitors of peanut allergens

In a new study published in the Proceedings of the National Academy of Sciences, researchers at the University of Notre Dame have effectively prevented the binding of peanut allergens with immunoglobulin E to suppress the allergic reaction to peanuts using a first-in-class design of allergen-specific inhibitors.

>Full Story

Allergic to the cure: Researchers create a new and quicker way to detect platin drug allergies for cancer patients

Platins, the most widely used chemotherapeutic drugs, are displaying an alarming rise in drug hypersensitivity reactions much more severe than the watery eyes or runny noses associated with hay fever, which is also a Type 1, immediate hypersensitivity reaction. A Notre Dame-led team has developed a safer way of determining hypersensitivity in patients.

>Full Story

Chang to receive AES Lifetime Achievement Award

Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering at the University of Notre Dame, has been selected to receive the AES Lifetime Achievement Award.

>Full Story

Matthew Webber receives American Diabetes Association’s Accelerator Award

nwelding • Date: February 19, 2019

The American Diabetes Association has announced that it will fund a $1.625 million Accelerator Award to Matthew Webber, assistant professor in the Department of Chemical and Bimolecular Engineering at the University of Notre Dame, to research and develop materials capable of sensing critical drops in blood glucose.

>Full Story

Notre Dame faculty members named to top one percent of highly cited researchers list for 2018

nwelding • Date: February 5, 2019

Professors Martin Haenggi and Prashant V. Kamat have been named to the Clarivate Analytics’ 2018 Highly Cited Researchers list.

>Full Story
Filed under: CBE
In the News Archives